Core Viewpoint - Robbins Geller Rudman & Dowd LLP is investigating potential violations of U.S. federal securities laws involving ALT5 Sigma Corporation, focusing on whether the company and its executives made false or misleading statements or failed to disclose material information to investors [1]. Company Overview - ALT5 Sigma Corporation operates in the blockchain technology sector through its Fintech and Biotechnology segments [2]. - The company announced plans to raise approximately $1.5 billion before fees through a registered direct offering and a private placement offering on August 11, 2025 [2]. Recent Developments - On August 29, 2025, ALT5 Sigma disclosed that its subsidiary, ALT5 Sigma Canada Inc., was found criminally liable for illicit enrichment and money laundering by a Rwandan court [3]. - An independent committee was appointed to investigate potential misstatements or omissions in the financial statements and material information by management [3]. - On October 22, 2025, the CEO, Peter Tassiopoulos, was suspended and removed from his duties [3]. - ALT5 Sigma announced on November 18, 2025, that it would not file its Quarterly Report on Form 10-Q on time [3]. - A leadership overhaul occurred on November 27, 2025, with the simultaneous departures of the CFO, Acting CEO, and COO, along with the appointment of a new Acting CEO and CFO [3]. - On November 28, 2025, the company disclosed the resignation of its independent registered public accounting firm, Hudgens CPA, PLLC [3]. - On December 3, 2025, ALT5 Sigma received a notice from Nasdaq regarding non-compliance with listing requirements due to the resignation of a board member [3].
ALT5 INVESTIGATION: Investigation Launched into ALT5 Sigma Corporation, Attorneys Encourage Investors and Potential Witnesses to Contact Law Firm - ALTS